Crossmark

Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model

Crossref DOI link: https://doi.org/10.1186/s13046-016-0392-1

Published Online: 2016-07-16

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Robl, Bernhard

Botter, Sander Martijn

Pellegrini, Giovanni

Neklyudova, Olga

Fuchs, Bruno
Funding

Funding for this research was provided by:

Universität Zürich

Schweizerischer Verein Balgrist

Walter L. und Johanna Wolf Foundation

Highly Specialized Medicine for Musculoskeletal Oncology

Kind und Krebs

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CH) (310030_149649)

Document is current

Any future updates will be listed below